---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-26-036499"
form_type: "8-K"
ticker: "TECH"
cik: "0000842023"
company_name: "BIO-TECHNE Corp"
filed_at: "2026-09-14T20:46:13+00:00"
generated_at: "2026-09-14T20:48:01.996807+00:00"
event_type: "litigation"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Bio-Techne discloses merger proxy lawsuit, supplements disclosures

## Summary
- Shareholder lawsuit filed Sept 9, 2026 in Minnesota court alleges proxy omitted material info; seeks to block merger vote.
- Bio-Techne denies merit, voluntarily supplements proxy; says disclosures comply with law.
- Supplement reveals Goldman Sachs implied present value of $58-$72/share (DCF) and $45-$74/share (multiple-based).
- Also discloses no post-closing employment discussions with merger parties from July 2025 to agreement execution.
- Special meeting for Merck KGaA merger vote remains scheduled for Sept 23, 2026.

## SEC filing metadata
- accession: 0001140361-26-036499
- form_type: 8-K
- ticker: TECH
- cik: 0000842023
- company_name: BIO-TECHNE Corp
- filed_at: 2026-09-14T20:46:13+00:00
- event_type: litigation
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/842023/000114036126036499/0001140361-26-036499-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/842023/000114036126036499/ef20081960_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-26-036499
- JSON: https://secwatch.observer/filing/0001140361-26-036499.json
- Plain text: https://secwatch.observer/filing/0001140361-26-036499.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.